Furthermore, Yang et al. indicated that low expression of TRAF3IP2-AS1 promotes the progression of NONO-TFE3 translocation renal cell carcinoma by stimulating the N6-methyladenosine of PARP1 mRNA and downregulating PTEN (Yang et al., 2021). Here, TRAF3IP2 is linked to hereditary clear cell renal cell carcinoma.